VWM
FBT icon

Vigilare Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Vigilare Wealth Management’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219K Buy
+885
New +$191K 0.07% 112

Other funds holding FBT

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
OPAM
Ocean Park Asset Management Santa Monica, California $2.08B AUM 5.32% 1-Year Est. Return
QCIG
Quad-Cities Investment Group Davenport, Iowa $278M AUM 22.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FEG
Financial Enhancement Group Anderson, Indiana $839M AUM 18.63% 1-Year Est. Return
TCOO
Trust Company of Oklahoma Tulsa, Oklahoma $389M AUM 34.72% 1-Year Est. Return
SP
Stablepoint Partners Braintree, Massachusetts $723M AUM 29.31% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

Vigilare Wealth Management's FBT Position: Q2 2026 in Review

Vigilare Wealth Management opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 885 shares worth $219K. The stake represents 0.07% of the portfolio and ranks #112 among its holdings.

59 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Vigilare Wealth Management held 885 shares of First Trust NYSE Arca Biotechnology Index Fund worth $219K as of Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund was a new Vigilare Wealth Management position in Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.07% of Vigilare Wealth Management's portfolio in Q2 2026, its #112 holding.
  • 59 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Vigilare Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.